GT199800063A - SELECTIVE CARPROPHEN FOR COX-2, FOR THE TREATMENT OF PAIN AND INFLAMMATION IN DOGS. - Google Patents

SELECTIVE CARPROPHEN FOR COX-2, FOR THE TREATMENT OF PAIN AND INFLAMMATION IN DOGS.

Info

Publication number
GT199800063A
GT199800063A GT199800063A GT199800063A GT199800063A GT 199800063 A GT199800063 A GT 199800063A GT 199800063 A GT199800063 A GT 199800063A GT 199800063 A GT199800063 A GT 199800063A GT 199800063 A GT199800063 A GT 199800063A
Authority
GT
Guatemala
Prior art keywords
dogs
inflammation
pain
treatment
carprophen
Prior art date
Application number
GT199800063A
Other languages
Spanish (es)
Inventor
Kristin Marie Lundy
Anthony Paul Ricketts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199800063A publication Critical patent/GT199800063A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

LA PRESENTE INVENCION SE REFIERE AL TRATAMIENTO DEL DOLOR Y DE LA INFLAMACION EN PERROS, CON AGENTES ANTIINFLAMATORIOS QUE SON FARMACOS ANTIINFLAMATORIOS NO ESTEROIDEOS (NSAID) Y, EN PARTICULAR, A AGENTES TALES QUE TIENEN UNA MENOR INCIDENCIA DE EFECTOS SECUNDARIOS GASTROINTESTINALES ADVERSOS, YA QUE TALES EFECTOS SECUNDARIOS SON UN PROBLEMA PREVALENTE Y POTENCIALMENTE GRAVE EN LOS PERROS. ESTOS COMPUESTOS TIENEN LA ESTRUCTURA QUIMICA (I), EN LA QUE R2, R6 Y R9, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE.THE PRESENT INVENTION REFERS TO THE TREATMENT OF PAIN AND INFLAMMATION IN DOGS, WITH ANTI-INFLAMMATORY AGENTS THAT ARE NON-STEROID ANTI-INFLAMMATORY DRUGS (NSAID) AND, IN PARTICULAR, TO SUCH AGENTS WITH SIDE EFFECTS AND SIDE EFFECTS. SIDE EFFECTS ARE A PREVALENT AND POTENTIALLY SERIOUS PROBLEM IN DOGS. THESE COMPOUNDS HAVE THE CHEMICAL STRUCTURE (I), IN WHICH R2, R6 AND R9 ARE FUNCTIONAL GROUPS DESCRIBED IN THE FILE.

GT199800063A 1997-05-05 1998-05-04 SELECTIVE CARPROPHEN FOR COX-2, FOR THE TREATMENT OF PAIN AND INFLAMMATION IN DOGS. GT199800063A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05

Publications (1)

Publication Number Publication Date
GT199800063A true GT199800063A (en) 1999-10-26

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199800063A GT199800063A (en) 1997-05-05 1998-05-04 SELECTIVE CARPROPHEN FOR COX-2, FOR THE TREATMENT OF PAIN AND INFLAMMATION IN DOGS.

Country Status (32)

Country Link
EP (1) EP0988034A1 (en)
JP (1) JP2000513020A (en)
KR (2) KR20040004406A (en)
CN (1) CN1255059A (en)
AP (1) AP9801234A0 (en)
AR (2) AR011726A1 (en)
AU (1) AU6932198A (en)
BG (1) BG103852A (en)
BR (1) BR9808720A (en)
CA (1) CA2288759A1 (en)
DZ (1) DZ2479A1 (en)
EA (1) EA003696B1 (en)
GT (1) GT199800063A (en)
HR (1) HRP980244A2 (en)
HU (1) HUP0001286A3 (en)
ID (1) ID21311A (en)
IL (1) IL132570A0 (en)
IS (1) IS5220A (en)
MA (1) MA26491A1 (en)
NO (1) NO995389L (en)
NZ (1) NZ500183A (en)
OA (1) OA11213A (en)
PA (1) PA8450601A1 (en)
PE (1) PE72599A1 (en)
PL (1) PL337003A1 (en)
SK (1) SK148199A3 (en)
TN (1) TNSN98059A1 (en)
TW (1) TW590773B (en)
UY (1) UY24989A1 (en)
WO (1) WO1998050033A1 (en)
YU (1) YU55899A (en)
ZA (1) ZA983722B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
CA2347365A1 (en) * 1998-10-23 2000-05-04 Merck Frosst Canada & Co. Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
EP1637137A3 (en) * 1999-03-10 2006-07-05 G.D. Searle LLC Method and composition for administering a cyclooxygenase-2 inhibitor to animals
AU1592901A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2004521856A (en) * 2000-05-15 2004-07-22 メルク フロスト カナダ アンド カンパニー Combination therapy using a COX-2 selective inhibitor and a thromboxane inhibitor and compositions therefor
BR0111767A (en) 2000-06-13 2003-07-08 Wyeth Corp Analgesic and anti-inflammatory compositions containing cox-2 inhibitors, their use and method for enhancing an analgesic compound
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
AU2001284753B2 (en) 2000-08-07 2006-10-26 Vanderbilt University Detection of COX-2 activity and anandamide metabolites
WO2003007875A2 (en) * 2001-07-16 2003-01-30 Hoegestaett Edward Compounds with analgesic, antipyretic and/or anti-inflammatory activity
JP4354984B2 (en) 2003-05-07 2009-10-28 オステオロジックス エイ／エス Treatment of cartilage / bone symptoms with water-soluble strontium salts
JP2007500691A (en) * 2003-07-31 2007-01-18 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Dispersible formulation of anti-inflammatory agent
CA2608010A1 (en) * 2005-05-20 2006-11-23 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
PT2079456E (en) 2007-04-04 2013-03-13 Sigmoid Pharma Ltd Pharmaceutical cyclosporin compositions
WO2008132707A1 (en) 2007-04-26 2008-11-06 Sigmoid Pharma Limited Manufacture of multiple minicapsules
BRPI1012196B1 (en) 2009-05-18 2021-11-30 Sublimity Therapeutics Limited COMPOSITION INCLUDING OIL DROPS
GB2485327A (en) 2009-08-12 2012-05-09 Sigmoid Pharma Ltd Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CN105939713A (en) * 2014-03-06 2016-09-14 阿莱塔纳治疗学股份有限公司 Compositions of grapiprant and methods for using same
CN107106644B (en) 2014-11-07 2022-04-15 卓越治疗有限公司 Cyclosporin-containing compositions
EP3242557A4 (en) * 2015-01-09 2018-09-05 Jaguar Health, Inc. Methods of treating diarrhea in companion animals
EP4125874A4 (en) * 2020-03-25 2024-05-01 Stanford Res Inst Int Lipoxygenase inhibitors
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (en) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 Pharmaceutical composition for preventing or treating keloid or hypertrophic scar comprising Benzbromarone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
YU55899A (en) 2003-08-29
EA003696B1 (en) 2003-08-28
NO995389L (en) 2000-01-04
EA199900895A1 (en) 2000-06-26
EP0988034A1 (en) 2000-03-29
NZ500183A (en) 2002-04-26
CN1255059A (en) 2000-05-31
WO1998050033A1 (en) 1998-11-12
JP2000513020A (en) 2000-10-03
TW590773B (en) 2004-06-11
SK148199A3 (en) 2001-09-11
AR011726A1 (en) 2000-08-30
TNSN98059A1 (en) 2005-03-15
PE72599A1 (en) 1999-08-12
IS5220A (en) 1999-10-19
ZA983722B (en) 1999-11-04
AP9801234A0 (en) 1999-11-04
KR20010012300A (en) 2001-02-15
PA8450601A1 (en) 2000-05-24
NO995389D0 (en) 1999-11-04
MA26491A1 (en) 2004-12-20
UY24989A1 (en) 2001-10-25
BG103852A (en) 2000-06-30
HRP980244A2 (en) 1999-02-28
IL132570A0 (en) 2001-03-19
BR9808720A (en) 2000-07-11
OA11213A (en) 2003-07-14
HUP0001286A3 (en) 2000-12-28
AU6932198A (en) 1998-11-27
PL337003A1 (en) 2000-07-31
CA2288759A1 (en) 1998-11-12
AR039628A2 (en) 2005-03-02
KR20040004406A (en) 2004-01-13
ID21311A (en) 1999-05-20
HUP0001286A2 (en) 2000-11-28
DZ2479A1 (en) 2003-02-01

Similar Documents

Publication Publication Date Title
GT199800063A (en) SELECTIVE CARPROPHEN FOR COX-2, FOR THE TREATMENT OF PAIN AND INFLAMMATION IN DOGS.
GT199600051A (en) (1S, 2S) -1- (4-HYDROXIPHENYL) -2- (4-HYDROXY-4- PHENYLPIPERIDIN-1-IL) -1-PROPANOL TRIHYDRATE METHANOLSULPHONATE.
GT199800021A (en) USE OF ANTAGONISTS OF CENTRAL CANABINOID RECEPTORS FOR THE PREPARATION OF MEDICINES.
GT200100211AA (en) COMPOSITES OF IMIDAZOL CONDENSED WITH ARILO OR HETEROARILO AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS. (PATENTEFRACTIONARY NO. 1 OF THE INVENTION PATENT APPLICATION NO. PI-2001-0211.
ECSP066575A (en) BRADIQUININE B1 RECEIVER ANTAGONISTS
CL2008003941A1 (en) Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a drug useful in the treatment of obsessive compulsive disorder.
GT199700089A (en) DERIVATIVES 6.6 OR 6.7-SUBSTITUTED BICYCLES CONTAINING PIRIDO OR PIRIMIDO.
GT199800171A (en) DIRECT OR INDIRECT SELECTIVE INHIBITORS OF FACTOR XA.
DE60233944D1 (en) ACTIVE DUTY SYSTEMS
AR021981A1 (en) PHARMACEUTICAL COMPOSITION FOR AN ORAL ROUTE ADMINISTRATION TO AVOID THE DEVIATION OF USE THROUGH A THIRD PARTY
BR0112054A (en) Micelle-forming composition, and methods for administration and protection of a therapeutic agent
DE69832816D1 (en) ORAL PHARMACEUTICAL DOSAGE FORM WITH EXTENDED DRUG RELIEF
CL2004000674A1 (en) TRANSDERMAL THERAPEUTIC SYSTEM THAT UNDERSTANDS AT LEAST AN ACTIVE PHARMACEUTICAL SUBSTANCE, AT LEAST A STRUCTURE DISRUPTOR AND / OR AT LEAST A STRUCTURE FORMATOR IN A COMMON MATRIX.
UY27511A1 (en) NEW ANDIDIABÉTIC AGENTS
AR027091A1 (en) DOSAGE FORM OF DRUGS DRIVEN BY A HYDROGEL
ATE295608T1 (en) POWER CABLE
UY27296A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING MOSAPRIDE AND PANCREATIN
GT199800205A (en) INDOL 2,3-SUBSTITUTED COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS.
TR200201071T2 (en) Emphysema treatment using Rar selective retinoid antagonists
ES2221950T3 (en) DIHYDROBENZOFURAN AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS.
DE69619052T2 (en) Solid, anhydrous, pharmaceutical preparations for vaginal use
AR030957A1 (en) ANALGESIC AND GLUCOSAMINE COMPOSITIONS
ECSP034858A (en) ORAL ADMINISTRATION OF HORMONE PARATIROIDES AND CALCITONINE
GT199800039A (en) ATROPISOMEROS OF 3-HETEROARIL-4 (3H) -QUINAZOLINONAS.
AR030662A1 (en) BETA-TIO-ALFA-AMINO ACIDS, PROCEDURE FOR MANUFACTURING, MEDICINES CONTAINING THESE COMPOUNDS AND THE USE OF THIOAMINO ACIDS FOR THE PREPARATION OF MEDICINES